Video

What Should Pharmacists Advise Patients Taking Aspirin and Rivaroxaban, if Approved?

Conference|ESC Congress - European Society of Cardiology Congress

In this clip, Deepak Bhatt, MD, discusses how pharmacists should counsel patients taking aspirin and rivaroxaban, if approved.

In this clip, Deepak Bhatt, MD, discusses how pharmacists should counsel patients taking aspirin and rivaroxaban, if approved.

Related Videos
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Woman professional nutritionist checking dietary supplements in hand, surrounded by a variety of fruits, nuts, vegetables, and dietary supplements on the table - Image credit: amenic181 | stock.adobe.com
Related Content
Drug Prices, Ozempic, Biktarvy | Image Credit: lucid_dream | stock.adobe.com
January 21st 2025

Ozempic, Biktarvy Among the Drugs Seeing List Price Increases at the Start of 2025

Ashley Gallagher, Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
Cardiovascular Disease, Polypill, Affordability, Adherence | Image Credit: santoelia | stock.adobe.com
January 21st 2025

Polypill Treatment for Cardiovascular Disease Shows Affordability for Majority Black Populations

Ashley Gallagher, Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
woman holding hands near head while suffering from headache in bedroom - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
January 21st 2025

Educate Patients About Nonprescription Products for Self-Treatment of Headaches

Yvette C. Terrie, BSPharm, RPh
https://mjh.sanity.studio/pharmacytimes/structure/article;f92c7f62-819f-4824-89b7-593f5761b127%2Ctemplate%3Darticle
January 21st 2025

Esketamine Receives FDA Approval for Adults With Treatment-Resistant Depression

Alexandra Gerlach, Associate Editor